© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
May 16, 2022
Adding darolutamide to androgen deprivation therapy and docetaxel did not increase the incidence or severity of adverse events in patients with metastatic hormone-sensitive prostate cancer.
February 21, 2022
Immunotherapy with or without radiotherapy did not demonstrate significant efficacy in patients with advanced squamous cell carcinoma of the penis, according to findings from the phase 2 PERICLES trial.